Clicky

Depression

Monocyte-to-Lymphocyte Ratio is Associated with Depression 3 Months Af

Kai-qi Ding,* Ze-hua Lai,* Yu Zhang, Guo-yuan Yang, Ji-rong He, Li-li Zeng Department of Neurology and Institute of Neurology, Ruijin Hospital/Luwan Branch, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China *These authors contributed equally to this work Correspondence: Li-li Zeng No. 197 Ruijin Second Road, Huangpu District, Shanghai, 200025, People’s Republic […]

Monocyte-to-Lymphocyte Ratio is Associated with Depression 3 Months Af Read More »

Group meta-cognitive therapy and depression in women with breast cancer: a randomized controlled trial | BMC Women’s Health

Design and setting This two-armed controlled clinical trial study was conducted in Shiraz in southern Iran. The study protocol was written in accordance with the CONSORT guidelines [22]. This study was conducted in the Breast Disease Research Center that is one of the largest breast disease research and treatment centers in southern Iran, which has

Group meta-cognitive therapy and depression in women with breast cancer: a randomized controlled trial | BMC Women’s Health Read More »

Transcendental Meditation effective in reducing PTSD, sleep problems, depression symptoms

IMAGE: Fifty percent of veterans who practiced the Transcendental Meditation technique for three months no longer met criteria for PTSD compared to only 10 percent of controls. Meditating veterans also showed… view more  Credit: Maharishi International University Research Institute Veterans with PTSD who practiced the Transcendental Meditation technique showed significant reductions in PTSD symptom severity, according

Transcendental Meditation effective in reducing PTSD, sleep problems, depression symptoms Read More »

Experts tackles topics from anxiety, depression in kids to self-care for parents

SAN ANTONIO – The last year has been full of challenges for everyone but especially for parents. Adapting to the threat of COVID-19, shutdowns, changes to school, childcare and social circles has been no easy task. While things seem more hopeful in recent weeks, parents are still battling with the effects of the pandemic. During

Experts tackles topics from anxiety, depression in kids to self-care for parents Read More »

More than 40% of people reported depression and anxiety symptoms since start of pandemic, survey finds

A year into the pandemic, a look at the mental health impact. (Photo: Getty Images) When COVID-19 was first reported in the United States, many were optimistic that it would come and go quickly enough. But after a few weeks, reality set in and took a toll, not only on our physical selves but on

More than 40% of people reported depression and anxiety symptoms since start of pandemic, survey finds Read More »

Allied Files Provisional Patent for Psilocybin Therapeutic Invention Seeking Drug Indication for Mental Health Depression and Anxiety Applications

KELOWNA, British Columbia, March 18, 2021 (GLOBE NEWSWIRE) — Allied Corp. (“Allied”) (OTCQB: ALID), an international medical cannabis company focused on creating and providing targeted psilocybin and cannabinoid health solutions to address today’s medical issues, is pleased to announce that it has submitted a provisional patent for the Allied therapeutic formulation and treatment regimen involving a

Allied Files Provisional Patent for Psilocybin Therapeutic Invention Seeking Drug Indication for Mental Health Depression and Anxiety Applications Read More »

Don’t Lose Sight of Biogen’s Depression Drug Amid Focus on Alzheimer’s Disease

Text size Biogen shares are up 7.9% so far this year and down 8.3% over the past 12 months. Dominick Reuter/AFP via Getty Images Investor conversations around the big biotech Biogen in recent months have focused on the company’s controversial Alzheimer’s disease drug, aducanumab, which the U.S. Food and Drug Administration is still deciding whether

Don’t Lose Sight of Biogen’s Depression Drug Amid Focus on Alzheimer’s Disease Read More »

Novamind Partners with Merck for New Treatment-Resistant Depression Trial

TipRanks 3 Big Dividend Stocks Yielding at Least 8%; Analysts Say ‘Buy’ Do you like roller coasters? According to Deutsche Bank, we’re looking at some roller coaster volatility for the next few months, with near-term gains likely, followed by a Q2 retreat, and second-half gains. The firm expects share values to fall in the next

Novamind Partners with Merck for New Treatment-Resistant Depression Trial Read More »